Apersy provide expert advisory services for Commercial Strategy and Market Access to integrate the commercial point of view throughout the development stages.
Its mission is to support clients in de-risking reimbursement and market access by providing strategic insights, supporting evidence generation planning, training and mentoring to meet the evidence requirements of payers and HTA bodies. Apersy builds on our longstanding experience in Health Economics, strategic pricing & reimbursement as well as investor due diligence & portfolio advisory to provide a holistic picture of commercial and access activities. Its specialist expertise lies in innovative biotech | digital healthcare & AI | regenerative & microbiome medicines.
Find out more about Apersy: www.apersy.com